In a unanimous and controversial 2012 ruling, the US Supreme Court held that Prometheus Laboratories could not patent a method of determining whether a patient is receiving an optimal amount of a therapeutic drug. The method relied on correlations between a patient’s response to certain drugs used to treat gastrointestinal disorders and the proper treatment dose.
Creative License: While their expertise ranges across patents, copyrights, and trademarks, NYU Law's formidable IP faculty explore a common question: What best drives innovation?
